Abstract
Treatment of spinal ependymoma is still challenging because of a concern of postoperative neurological deficit, which derived from its intramedullary location. Despite recent progression of adjuvant therapy, surgical resection is still a mainstay of the treatment, which can lead to an actual cure. To achieve successful surgical outcome minimizing the neurological deficits, the development and keeping the dissection plane throughout the tumor removal is the most important. Therefore, it is imperative to understand the anatomical relationship between the tumor and the surrounding tissues based on tumor origin. In this chapter, the authors suggest the concept of the intra-ependymal tumor, instead of the traditional intramedullary tumor for ependymoma based on the tumor origin and anatomical features. This concept may facilitate the development of the dissection plane and leads to the safe and effective removal of spinal ependymoma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wu J, Armstrong TS, Gilbert MR. Biology and management of ependymomas. Neuro Oncol. 2016;18:902–13.
Connolly ID, Ali R, Li Y, et al. Genetic and molecular distinctions in spinal ependymomas: a review. Clin Neurol Neurosurg. 2015;139:210–5.
Schweizer L, Sieber L, Volckmann R, et al. Molecular Classification of ependymal tumors across all CNS Compartments, histopathological grades, and age groups author contributions to the design and conduct of experiments and to the writing HHS public access. Cancer Cell. 2015;27:728–43.
Rushing EJ, Cooper PB, Quezado M, et al. Subependymoma revisited: clinicopathological evaluation of 83 cases. J Neurooncol. 2007;85:297–305.
Yuh WT, Chung CK, Park SH, et al. Spinal cord subependymoma surgery: a multi-institutional experience. J Korean Neurosurg Soc. 2018;61:233–42.
Taylor MD, Poppleton H, Fuller C, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell. 2005;8:323–35.
Barton VN, Donson AM, Kleinschmidt-Demasters BK, et al. Unique molecular characteristics of pediatric myxopapillary ependymoma. Brain Pathol. 2010;20:560–70.
Milano MT, Johnson MD, Sul J, et al. Primary spinal cord glioma: a surveillance, epidemiology, and end results database study. J Neurooncol. 2010;98:83–92.
Schellinger KA, Propp JM, Villano JL, et al. Descriptive epidemiology of primary spinal cord tumors. J Neurooncol. 2008;87:173–9.
Jung KW, Park KH, Ha J, et al. Incidence of primary spinal cord, spinal meninges, and cauda equina tumors in Korea, 2006–2010. Cancer Res Treat. 2015;47:166–72.
Khalid SI, Adogwa O, Kelly R, et al. Adult Spinal ependymomas: an epidemiologic study. World Neurosurg. 2018;111:e53-61.
McCormick PC, Stein BM. Intramedullary tumors in adults. Neurosurg Clin N Am. 1990;1:609–30.
Kobayashi K, Ando K, Kato F, et al. MRI characteristics of Spinal ependymoma in WHO grade II. Spine (Phila Pa 1976) 2018;43:E525–30.
Lee S, Chung CK, Kim CH, et al. with or without adjuvant radiation therapy for treatment of spinal ependymoma: a Spinal oncology research group. Neuro Oncol. 2013;15:921–9.
Samii M, Klekamp J. Surgical results of 100 intramedullary tumors in relation to accompanying syringomyelia. Neurosurgery 1994;35:865–73; discussion 873.
Klekamp J. Spinal ependymomas. Part 1: Intramedullary ependymomas. Neurosurg Focus 2015;39:E6.
Fine MJ, Kricheff II, Freed D, et al. Spinal cord ependymomas: MR imaging features. Radiology. 2014;197:655–8.
Cristante L, Herrmann HD. Surgical management of intramedullary spinal cord tumors: functional outcome and sources of morbidity. Neurosurgery. 1994;35:66–9.
Schwartz TH, McCormick PC. Intramedullary ependymomas: Clinical presentation, surgical treatment strategies and prognosis. J Neurooncol. 2000;47:211–8.
Epstein FJ, Farmer JP, Freed D. Adult intramedullary spinal cord ependymomas: The result of surgery in 38 patients. J Neurosurg. 1993;79:204–9.
Vera-Bolanos E, Aldape K, Yuan Y, et al. Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. Neuro Oncol. 2015;17:440–7.
Harrop JS, Ganju A, Groff M, et al. Primary Intramedullary tumors of the spinal cord. Spine (Phila Pa 1976) 2009;34:S69–77.
Oh MC, Ivan ME, Sun MZ, et al. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro Oncol. 2013;15:208–15.
Chamberlain MC. Etoposide for recurrent spinal cord ependymoma. Neurology 2002;58:1310–1.
Abd-El-Barr MM, Huang KT, Moses ZB, et al. Recent advances in intradural spinal tumors. Neuro Oncol. 2018;20:729–42.
Morris KA, Afridi SK, Evans DG, et al. The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2. J Neurosurg Spine. 2016;26:474–82.
Fakhrai N, Neophytou P, Dieckmann K, et al. Recurrent spinal ependymoma showing partial remission under Imatimib. Acta Neurochir (Wien). 2004;146:1255–8.
Essayed WI, Bernard A, Kalamarides M. Clinical response associated with radiographic regression of a cervicomedullary ependymoma in a NF2 patient treated by bevacizumab. J Neurooncol. 2015;125:445–6.
Yeboa DN, Liao K ping, Guadagnolo BA, et al. National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas. World Neurosurg 2019;124:e580–94.
Tao X, Hou Z, Hao S, et al. The clinical features and surgical outcomes of spinal cord tanycytic ependymomas: a report of 40 cases. World Neurosurg. 2017;106:60–73.
Keil VC, Schmitt AJ, Martin SC, et al. Optimising treatment strategies in spinal ependymoma based on 20 years of experience at a single centre. J Clin Neurosci. 2016;29:52–8.
Wild F, Hartmann C, Heissler HE, et al. Surgical treatment of spinal ependymomas: experience in 49 patients. World Neurosurg. 2018;111:e703–9.
Behmanesh B, Gessler F, Dützmann S, et al. Natural history of intramedullary spinal cord ependymoma in patients preferring nonoperative treatment. J Neurooncol. 2017;135:93–8.
Yanni DS, Ulkatan S, Deletis V, et al. Utility of neurophysiological monitoring using dorsal column mapping in intramedullary spinal cord surgery. J Neurosurg Spine. 2010;12:623–8.
Nagasawa DT, Smith ZA, Cremer N, et al. Complications associated with the treatment for spinal ependymomas. Neurosurg Focus. 2011;31:E13.
Jin SH, Chung CK, Kim CH, et al. Multimodal intraoperative monitoring during intramedullary spinal cord tumor surgery. Acta Neurochir (Wien). 2015;157:2149–55.
Sohn S, Chung CK, Kim CH. Is closed-suction drainage necessary after intradural primary spinal cord tumor surgery? Eur Spine J. 2013;22:577–83.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
14.1 Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Supplementary material 1 (AVI 2,46,917 kb)
Supplementary material 2 (MP4 83.688 kb)
Supplementary material 3 (MOV 13,64,047 kb)
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yang, S.H., Chung, C.K. (2021). How to Approach Anatomical Compartment; Intrapial Intra-Ependymal Tumor. In: Chung, C.K. (eds) Surgery of Spinal Cord Tumors Based on Anatomy. Springer, Singapore. https://doi.org/10.1007/978-981-15-7771-0_14
Download citation
DOI: https://doi.org/10.1007/978-981-15-7771-0_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7770-3
Online ISBN: 978-981-15-7771-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)